Arrowhead Pharmaceuticals (ARWR) Return on Sales (2016 - 2025)
Historic Return on Sales for Arrowhead Pharmaceuticals (ARWR) over the last 16 years, with Q4 2025 value amounting to 0.11%.
- Arrowhead Pharmaceuticals' Return on Sales rose 701900.0% to 0.11% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.21%, marking a year-over-year increase of 2600300.0%. This contributed to the annual value of 0.04% for FY2025, which is 1717300.0% up from last year.
- Latest data reveals that Arrowhead Pharmaceuticals reported Return on Sales of 0.11% as of Q4 2025, which was up 701900.0% from 0.06% recorded in Q3 2025.
- In the past 5 years, Arrowhead Pharmaceuticals' Return on Sales ranged from a high of 0.68% in Q1 2025 and a low of 171.7% during Q3 2024
- Moreover, its 5-year median value for Return on Sales was 2.26% (2021), whereas its average is 17.54%.
- In the last 5 years, Arrowhead Pharmaceuticals' Return on Sales tumbled by -1648000bps in 2024 and then surged by 1717600bps in 2025.
- Quarter analysis of 5 years shows Arrowhead Pharmaceuticals' Return on Sales stood at 2.29% in 2021, then soared by 71bps to 0.67% in 2022, then tumbled by -5603bps to 38.12% in 2023, then plummeted by -84bps to 70.09% in 2024, then skyrocketed by 100bps to 0.11% in 2025.
- Its Return on Sales was 0.11% in Q4 2025, compared to 0.06% in Q3 2025 and 6.43% in Q2 2025.